Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
Gurrieri L, Mercatali L, Ibrahim T, Fausti V, Dall'Agata M, Riva N, Ranallo N, Pasini G, Tazzari M, Foca F, Bartolini D, Riccioni L, Cavatorta C, Morigi FP, Bulgarelli J, Cocchi C, Ghini V, Tosatto L, Martinelli G, Pession A, Ridolfi L. Gurrieri L, et al. Among authors: ridolfi l. J Neurooncol. 2023 Aug;164(1):55-64. doi: 10.1007/s11060-023-04357-9. Epub 2023 Aug 16. J Neurooncol. 2023. PMID: 37584750 Free PMC article.
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.
Ridolfi L, Bertetto O, Santo A, Naglieri E, Lopez M, Recchia F, Lissoni P, Galliano M, Testore F, Porta C, Maglie M, Dall'agata M, Fumagalli L, Ridolfi R. Ridolfi L, et al. Among authors: ridolfi r. Int J Oncol. 2011 Oct;39(4):1011-7. doi: 10.3892/ijo.2011.1099. Epub 2011 Jun 24. Int J Oncol. 2011. PMID: 21720704 Clinical Trial.
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases.
Queirolo P, Spagnolo F, Ascierto PA, Simeone E, Marchetti P, Scoppola A, Del Vecchio M, Di Guardo L, Maio M, Di Giacomo AM, Antonuzzo A, Cognetti F, Ferraresi V, Ridolfi L, Guidoboni M, Guida M, Pigozzo J, Chiarion Sileni V. Queirolo P, et al. Among authors: ridolfi l. J Neurooncol. 2014 May;118(1):109-16. doi: 10.1007/s11060-014-1400-y. Epub 2014 Feb 16. J Neurooncol. 2014. PMID: 24532241 Free PMC article.
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience.
de Rosa F, Ridolfi L, Fiammenghi L, Petrini M, Granato AM, Ancarani V, Pancisi E, Soldati V, Cassan S, Bulgarelli J, Framarini M, Tauceri F, Migliori G, Brolli C, Gentili G, Petracci E, Nanni O, Riccobon A, Ridolfi R, Guidoboni M. de Rosa F, et al. Among authors: ridolfi r, ridolfi l. Melanoma Res. 2017 Aug;27(4):351-357. doi: 10.1097/CMR.0000000000000356. Melanoma Res. 2017. PMID: 28654547
Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone.
Bulgarelli J, Fiammenghi L, Cassan S, Granato AM, Petrini M, Pancisi E, Soldati V, De Rosa F, Ridolfi L, Riccobon A, Guidoboni M. Bulgarelli J, et al. Among authors: ridolfi l. Cytotherapy. 2018 Jun;20(6):851-860. doi: 10.1016/j.jcyt.2018.04.002. Epub 2018 May 10. Cytotherapy. 2018. PMID: 29754770 Free article.
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial).
Ridolfi L, de Rosa F, Fiammenghi L, Petrini M, Granato AM, Ancarani V, Pancisi E, Soldati V, Cassan S, Bulgarelli J, Riccobon A, Gentili G, Nanni O, Framarini M, Tauceri F, Guidoboni M. Ridolfi L, et al. BMJ Open. 2018 Aug 5;8(8):e021701. doi: 10.1136/bmjopen-2018-021701. BMJ Open. 2018. PMID: 30082356 Free PMC article.
Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors.
Bulgarelli J, Tazzari M, Granato AM, Ridolfi L, Maiocchi S, de Rosa F, Petrini M, Pancisi E, Gentili G, Vergani B, Piccinini F, Carbonaro A, Leone BE, Foschi G, Ancarani V, Framarini M, Guidoboni M. Bulgarelli J, et al. Among authors: ridolfi l. Front Immunol. 2019 Oct 9;10:2353. doi: 10.3389/fimmu.2019.02353. eCollection 2019. Front Immunol. 2019. PMID: 31649669 Free PMC article. Clinical Trial.
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma.
Bulgarelli J, Piccinini C, Petracci E, Pancisi E, Granato AM, de Rosa F, Guidoboni M, Petrini M, Ancarani V, Foschi G, Romeo A, Tontini L, De Giorgi U, Lolli C, Gentili G, Valmorri L, Rossi A, Ferroni F, Casadei C, Cortesi P, Crudi L, Ridolfi L. Bulgarelli J, et al. Among authors: ridolfi l. Front Immunol. 2021 Oct 27;12:778459. doi: 10.3389/fimmu.2021.778459. eCollection 2021. Front Immunol. 2021. PMID: 34777395 Free PMC article. Clinical Trial.
Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center.
Pancisi E, Granato AM, Scarpi E, Ridolfi L, Carloni S, Moretti C, Guidoboni M, De Rosa F, Pignatta S, Piccinini C, Soldati V, Calabrò L, Framarini M, Stefanelli M, Bulgarelli J, Tazzari M, Fanini F, Petrini M. Pancisi E, et al. Among authors: ridolfi l. Vaccines (Basel). 2022 Jun 23;10(7):999. doi: 10.3390/vaccines10070999. Vaccines (Basel). 2022. PMID: 35891165 Free PMC article.
194 results